velaglucerase alfa
Selected indexed studies
- Velaglucerase alfa. (, 2006) [PMID:30000768]
- Velaglucerase alfa. (Nat Rev Drug Discov, 2010) [PMID:21030995]
- Velaglucerase alfa for the management of type 1 Gaucher disease. (Clin Ther, 2012) [PMID:22264444]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Velaglucerase alfa. (2006) pubmed
- Velaglucerase alfa. (2010) pubmed
- Velaglucerase alfa for the management of type 1 Gaucher disease. (2012) pubmed
- Velaglucerase alfa, a human recombinant glucocerebrosidase enzyme replacement therapy for type 1 Gaucher disease. (2010) pubmed
- Rapid velaglucerase alfa infusion for Gaucher disease: 5-year data. (2022) pubmed
- 13,845 home therapy infusions with velaglucerase alfa exemplify safety of velaglucerase alfa and increased compliance to every-other-week intravenous enzyme replacement therapy for Gaucher disease. (2015) pubmed
- Velaglucerase alfa as a therapeutic option for Gaucher disease. (2011) pubmed
- Development of anti-velaglucerase alfa antibodies in clinical trial-treated patients with Gaucher disease. (2016) pubmed
- Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease. (2013) pubmed
- Rapid home therapy infusion of velaglucerase alfa in naïve patients with Gaucher disease. (2024) pubmed